The global MEK Inhibitors Market is poised for substantial growth as the demand for targeted cancer therapies continues to rise. MEK inhibitors, a class of targeted drugs, play a crucial role in controlling abnormal cell proliferation by blocking the MAPK/ERK pathway, widely associated with cancer development. The market is driven by increasing incidences of melanoma, lung cancer, and other...